ES2096917T3 - Sistema de deteccion de nicotina y/o de metabolitos de la nicotina. - Google Patents

Sistema de deteccion de nicotina y/o de metabolitos de la nicotina.

Info

Publication number
ES2096917T3
ES2096917T3 ES93912132T ES93912132T ES2096917T3 ES 2096917 T3 ES2096917 T3 ES 2096917T3 ES 93912132 T ES93912132 T ES 93912132T ES 93912132 T ES93912132 T ES 93912132T ES 2096917 T3 ES2096917 T3 ES 2096917T3
Authority
ES
Spain
Prior art keywords
nicotine
solid phase
metabolites
detection system
color
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93912132T
Other languages
English (en)
Inventor
Amruta R Eswara
Neal Muni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DynaGen Inc
Original Assignee
DynaGen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DynaGen Inc filed Critical DynaGen Inc
Application granted granted Critical
Publication of ES2096917T3 publication Critical patent/ES2096917T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465Nicotine; Derivatives thereof
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N31/00Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
    • G01N31/22Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N31/00Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
    • G01N31/22Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators
    • G01N31/221Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators for investigating pH value
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/521Single-layer analytical elements
    • G01N33/523Single-layer analytical elements the element being adapted for a specific analyte
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/815Test for named compound or class of compounds
    • Y10S436/816Alkaloids, amphetamines, and barbiturates
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555Hetero-N
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555Hetero-N
    • Y10T436/147777Plural nitrogen in the same ring [e.g., barbituates, creatinine, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)

Abstract

SE DESCRIBE UNA FASE SOLIDA CAPAZ DE DETECTAR LA PRESENCIA DE NICOTINA Y/O METABOLITOS DE NICOTINA. LA FASE SOLIDA SE IMPREGNA CON REAGENTES DE ENSAYO QUE INCLUYEN UN DETERMINANTE DEL COLOR, UN NEUTRALIZADOR, UN AGENTE LIBERADOR DE CIANOGENO Y UN AGENTE FORMADOR DE ALURO DE CIANOGENO. LA FASE SOLIDA SUMINISTRA UN MEDIO MEDIANTE EL CUAL MUESTRAS NO PROCESADAS DE ORINA A LO LARGO DE UNA AMPLIA BANDA DE DIFERENTES VALORES DE PH PUEDEN SER COMPROBADAS PARA LOCALIZAR LA PRESENCIA DE NICOTINA Y/O METABOLITOS DE NICOTINA. LOS RESULTADOS DEL ENSAYO PUEDEN DETERMINARSE MEDIANTE VISUALIZACION DIRECTA DEL COLOR DE LA FASE SOLIDA. TAMBIEN SE DESCRIBEN METODOS PARA PREPARAR Y UTILIZAR LA FASE SOLIDA, Y EQUIPOS QUE CONTIENEN LA FASE SOLIDA.
ES93912132T 1992-04-02 1993-04-02 Sistema de deteccion de nicotina y/o de metabolitos de la nicotina. Expired - Lifetime ES2096917T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86205192A 1992-04-02 1992-04-02

Publications (1)

Publication Number Publication Date
ES2096917T3 true ES2096917T3 (es) 1997-03-16

Family

ID=25337511

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93912132T Expired - Lifetime ES2096917T3 (es) 1992-04-02 1993-04-02 Sistema de deteccion de nicotina y/o de metabolitos de la nicotina.

Country Status (8)

Country Link
US (1) US5707872A (es)
EP (1) EP0634013B1 (es)
AT (1) ATE144836T1 (es)
AU (1) AU4279193A (es)
CA (1) CA2133415A1 (es)
DE (1) DE69305737T2 (es)
ES (1) ES2096917T3 (es)
WO (1) WO1993020438A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9301288D0 (en) * 1993-01-22 1993-03-17 Univ Birmingham Method of assaying
US5733787A (en) * 1996-06-17 1998-03-31 Bayer Corporation Method for the detection of creatinine
US6472222B2 (en) 1999-02-16 2002-10-29 Via Christi Research, Inc. Method of estimating rate of nicotine metabolism in individuals
US20070031914A1 (en) * 2005-08-05 2007-02-08 Wei Zhu Devices for analyte assays and methods of use
US20080299585A1 (en) * 2006-12-18 2008-12-04 Paul Truex METHODS FOR DETECTION AND MEASUREMENT OF SECRETORY PHOSPHOLIPASE A2 LEVELS (sPLA2) IN BIOLOGICAL FLUIDS
WO2008137749A1 (en) * 2007-05-04 2008-11-13 Upspring Ltd. Diagnostic device and method for testing hydration and other conditions
GB201008039D0 (en) * 2010-05-13 2010-06-30 Gfc Diagnostics Ltd Detection of nicotine metabolites
KR101427988B1 (ko) * 2012-01-31 2014-08-08 주식회사 디에프아이 흡연 유무 검출수단

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160008A (en) * 1978-01-26 1979-07-03 Miles Laboratories, Inc. Multilayered test device for determining the presence of a liquid sample component, and method of use
JPS5877661A (ja) * 1981-11-02 1983-05-11 Fuji Photo Film Co Ltd アンモニアまたはアンモニア生成基質分析用一体型多層分析材料および検出法

Also Published As

Publication number Publication date
EP0634013A1 (en) 1995-01-18
DE69305737T2 (de) 1997-05-22
ATE144836T1 (de) 1996-11-15
US5707872A (en) 1998-01-13
WO1993020438A1 (en) 1993-10-14
DE69305737D1 (de) 1996-12-05
CA2133415A1 (en) 1993-10-14
AU4279193A (en) 1993-11-08
EP0634013B1 (en) 1996-10-30

Similar Documents

Publication Publication Date Title
AU3569689A (en) Assay device and immunoassay
ATE113962T1 (de) Von polypeptiden induzierte monoklonale antikörper gegen oncoproteine.
DK0533719T3 (da) Fremgangsmåde til påvisning og/eller bestemmelse af hormoner
ES2096917T3 (es) Sistema de deteccion de nicotina y/o de metabolitos de la nicotina.
ATE177533T1 (de) Verfahren zur bestimmung einer immunologischen aktiven substanz mittels magnetischer latexteilchen und nichtmagnetischer teilchen
EP1083428A3 (en) Method and reagent for the detection or determination of HCV core antigens
DE3850249D1 (de) Nachweis von analyt in partikel enthaltenden proben.
ATE320604T1 (de) Homogene nachweisverfahren zur bestimmung von subpopulationen eines analyten
HUP9800225A2 (hu) Eljárás és vegyületek analitok meghatározására remanenciaméréssel és ezek alkalmazásai
CA2303123A1 (en) Method for detecting antibodies in a sample
FI850717L (fi) Iontesthjaelpmedel med poroes baermatris.
ATE81405T1 (de) System und verfahren fuer eine visuelle probe einer zu bestimmenden substanz.
AU636964B2 (en) Immunological detection of metolachlor
MY106868A (en) Stabilizing reagent for membrane immunoassay.
ATE286596T1 (de) Chemische modifikation von antikörpern und antigenen
CA2123069A1 (en) Immunoassay for analytes in samples using alkylating agents
KR860007545A (ko) 인체 프로릴 4-히드록시라아제의 정량 방법
KR940004326A (ko) 티록신 또는 트리요오도티로닌의 측정을 위한 방법 및 표준용액
BR9102727A (pt) Processo para a preparacao de um anticorpo monoclonal, anticorpos monoclonais, linha de celulas, processo para sua preparacao, processo para a determinacao imunologica de herbicidas de sulfonilureia, agente para determinacao imunologica, componente de copulacao e processo para a preparacao de um componente

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 634013

Country of ref document: ES